NCT06968338 A Study to Assess the Safety of ARGX-213 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT06920004 A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP Status RECRUITING Phase PHASE3
NCT06909214 A Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With New-onset Generalized Myasthenia Gravis (gMG) Status RECRUITING Phase PHASE4
NCT06860633 Treatment of Myasthenia Gravis Exacerbation or Crisis With Efgartigimod Status RECRUITING Phase PHASE4
NCT06799416 A Study to Assess the Safety of ARGX-109 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT06742190 A Study to Assess the Efficacy and Safety of Empasiprubart Versus IVIg in Adults With Multifocal Motor Neuropathy Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06688253 Intravenous Human IgG1 Fc Fragment (Efgartigimod) in Myasthenic Crisis Status NOT_YET_RECRUITING Phase PHASE4
NCT06684847 A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's Syndrome Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06655155 A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis Status RECRUITING Phase PHASE2
NCT06637072 A Study to Assess Adults With CIDP Transitioning From IVIg to Efgartigimod PH20 SC Status COMPLETED Phase PHASE4
NCT06558279 A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults With Ocular Myasthenia Gravis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06544499 A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia Status RECRUITING Phase PHASE3
NCT06503731 A Study to Evaluate the Safety and Tolerability of Efgartigimod PH20 SC Given by Prefilled Syringe in Kidney Transplant Recipients With Antibody-Mediated Rejection (AMR) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06441682 A Safety and Efficacy Study of ARGX-119 in Adult Patients With Amyotrophic Lateral Sclerosis (ALS) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06436742 A Phase 1b Study to Investigate Safety and Tolerability of ARGX-119 in Adult Participants With DOK7-Congenital Myasthenic Syndromes (CMS) Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06392386 A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis Status RECRUITING Phase PHASE2/PHASE3
NCT06307626 A Study of Efgartigimod PH20 SC Given by Prefilled Syringe in Adults With Thyroid Eye Disease. Status TERMINATED Phase PHASE3
NCT06307613 A Study of Efgartigimod PH20 SC Given by Prefilled Syringe in Adults With Thyroid Eye Disease Status TERMINATED Phase PHASE3